Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Neuroectodermal Tumors, Primitive × Lomustine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Recurrence 2 Brain Neoplasms 2 Astrocytoma 2 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Medulloblastoma 1 Glioma 1 Central Nervous System Neoplasms 1

Interventions

Vincristine 1 Radiotherapy 1 Maintenance Chemotherapy 1 Lomustine 1 Induction Chemotherapy 1 Diploidy 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Active not recruiting

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡